# aTYR PHARMA INC: Form 8-K, filed Sep 26, 2023

- Company: [aTYR PHARMA INC](/companies/atyr.md) (CIK 1339970)
- Form: 8-K
- Filed: 2023-09-26
- Accepted by EDGAR: Sep 26, 2023, 09:01 ET
- Period: 2023-09-26
- Accession: 0000950170-23-049802
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1339970/000095017023049802/life-20230926.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1339970/000095017023049802/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1339970/000095017023049802/life-20230926.htm

Filed Sep 26, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-049802. Last ingested by Listed: Oct 27, 2026, 09:04 ET. No prices; not investment advice.